Following an abbreviated submission.
Triptorelin 11.25mg vial for injection (Decapeptyl SR®) is accepted for use in NHS Scotland for the treatment of precocious puberty (onset before 8 years in girls and 9 years in boys).
For patients for whom this drug is appropriate, it is associated with an increased dose interval (3 months vs. 1 month) and reduced costs compared to an existing pre-filled syringe formulation of triptorelin.
Download detailed advice29KB (PDF)
- Medicine name:
- triptorelin 11.25mg vial for injection (Decapeptyl SR)
- SMC ID:
- Precocious puberty
- Pharmaceutical company
- Ipsen Ltd
- BNF chapter
- Endocrine system
- Submission type
- Date advice published
- 11 December 2006